Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2885-2890

  O'Seaghdha, Conall M ^a,b   Hwang, Shih Jen ^a   Muntner, Paul ^c,d   Melamed, Michal L ^e   Fox, Caroline S ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CKD; ESRD; phosphorus

Indexed keywords

PHOSPHORUS;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITION SURVEYS; PHOSPHORUS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES;

EID: 80053211737     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq808     Document Type: Article

References (47)

1. Muntner P, Vupputuri S, Coresh J et al. Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int 2009; 76: 81-88
2. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13: 504-510 (Pubitemid 34106294)
3. Ensrud KE, Lui LY, Taylor BC et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007; 167: 133-139 (Pubitemid 46148060)
4. Fried LF, Shlipak MG, Crump C et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364-1372 (Pubitemid 36438998)
5. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315 (Pubitemid 38526012)
6. U.S. Renal Data System. 2009 Annual Data Report. Bethesda, MD: NIH/NIDDK, 2010
7. Neves KR, Graciolli FG, dos Reis LM et al. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004; 66: 2237-2244 (Pubitemid 41115286)
8. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916 (Pubitemid 350093423)
9. Norris KC, Greene T, Kopple J et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 2006; 17: 2928-2936 (Pubitemid 44484684)
10. Schwarz S, Trivedi BK, Kalantar-Zadeh K et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 825-831
11. Nakamura S, Ishibashi-Ueda H, Niizuma S et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900
12. Ichikawa S, Imel EA, Kreiter ML et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007; 117: 2684-2691 (Pubitemid 47494368)
13. Kannel WB, Feinleib M, McNamara PM et al. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281-290 (Pubitemid 10204328)
14. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994; 32: 1-407
15. Culleton BF, Larson MG, Parfrey PS et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 2000; 109: 1-8 (Pubitemid 30608730)
16. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 (Pubitemid 29135798)
17. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850 (Pubitemid 38543772)
18. Bash LD, Coresh J, Kottgen A et al. Defining incident chronic kidney disease in the research setting: The ARIC Study. Am J Epidemiol 2009; 170: 414-424
19. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920-929 (Pubitemid 34454210)
20. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885 (Pubitemid 46762749)
21. Tonelli M, Sacks F, Pfeffer M et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633 (Pubitemid 41532599)
22. Freedman BI, Dubose TD Jr. Chronic kidney disease: cause and consequence of cardiovascular disease. Arch Intern Med 2007; 167: 1113-1115 (Pubitemid 46919812)
23. Moe SM, Drueke T, Lameire N et al. Chronic kidney disease-mineralbone disorder: a new paradigm. Adv Chronic Kidney Dis 2007; 14: 3-12 (Pubitemid 46014534)
24. Berndt T, Thomas LF, Craig TA et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 2007; 104: 11085-11090 (Pubitemid 47175230)
25. Nishida Y, Taketani Y, Yamanaka-Okumura H et al. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 2006; 70: 2141-2147 (Pubitemid 44871378)
26. Bell RR, Draper HH, Tzeng DY et al. Physiological responses of human adults to foods containing phosphate additives. J Nutr 1977; 107: 42-50 (Pubitemid 8030952)
27. Herrin RC RA, Feinstein RN. The influence of diet upon urea clearance in dogs. Am J Physiol 1937; 119: 87-92
28. Bilo HJ, Schaap GH, Blaak E et al. Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency. Nephron 1989; 53: 181-187 (Pubitemid 19237475)
29. Knight EL, Stampfer MJ, Hankinson SE et al. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003; 138: 460-467
30. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-659 (Pubitemid 12049914)
31. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12: 1315-1325 (Pubitemid 32472647)
32. Dworkin LD, Hostetter TH, Rennke HG et al. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 1984; 73: 1448-1461
33. Dworkin LD, Feiner HD. Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest 1986; 77: 797-809 (Pubitemid 16067952)
34. Nath KA, Kren SM, Hostetter TH. Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. J Clin Invest 1986; 78: 1199-1205 (Pubitemid 17181557)
35. Meyer TW, Anderson S, Rennke HG et al. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-759 (Pubitemid 17025906)
36. Hostetter TH, Meyer TW, Rennke HG et al. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986; 30: 509-517 (Pubitemid 16000796)
37. Zeller K, Whittaker E, Sullivan L et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78-84
38. Walker JD, Bending JJ, Dodds RA et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2: 1411-1415 (Pubitemid 20012057)
39. Ihle BU, Becker GJ, Whitworth JA et al. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989; 321: 1773-1777 (Pubitemid 20015569)
40. Calvo MS, Park YK. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr 1996; 126 (4 Suppl): 1168S-11680S
41. Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20: 295-301
42. Gutierrez OM, Isakova T, Enfield G et al. Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey. J Ren Nutr 2010; May 25 [epub ahead of print]
43. Ferro CJ, Chue CD, Steeds RP et al. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart 2009; 95: 1770-1772
44. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008; 19: 213-216 (Pubitemid 351240642)
45. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
46. Shankar A, Lee KE, Klein BE et al. Estimating glomerular filtration rate in a population-based study. Vasc Health Risk Manag 2010; 6: 619-627
47. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528 (Pubitemid 41725150)